IL18 and breast cancer: To our knowledge, only three studies have examined the influence of IL18 genetic variations (–137G/C and –607A/C) on BC susceptibility; Khalili-Azad et al. [11] studied the effect of IL18 polymorphisms (–607A/C and –137G/C) on BC risk in 200 patients and 206 healthy controls.